Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Positive Fasd Education Brochure

Research Leaders

8 sponsors active, led by University Of Oklahoma

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT02558933Not ApplicableCompletedPrimary

Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children

NCT01961050Not ApplicableCompletedPrimary

Preventing FAS/ARND in Russian Children

NCT01971398Not ApplicableCompleted

Development of Education Materials for Prevention of FAS in Russia

Showing all 3 trials

Research Network

Common Treatments

  • Positive Fasd Education Brochure1
  • Services As Usual1
  • Negative Fasd Education Brochure1
  • Active Comparator A General Womens Health Brochure1
  • Dualfocused Brief Physician Intervention Dfbpi1

Active Sponsors

  • University Of Oklahoma2
  • St Petersburg State Pavlov Medical University1
  • Parc De Salut Mar1
  • Centers For Disease Control And Prevention1
  • Fogarty International Center Of The National Institute Of Health1

Related Conditions

  • Fetal Alcohol Spectrum Disorders2
  • Alcohol Use Complicating Pregnancy Unspecified Trimester1
  • Alcohol Abuse In Pregnancy1
  • Alcohol Related Neurodevelopmental Disorder1

Activity Timeline